OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9805	Companies
196660	Keywords
127679	Articles
104559	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 05/28/2025 at 18:00, 8 months 7 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelenbezit volgens Belgische wetgeving. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Bedrijf Belgische Wetgeving Atlas Special Opportunities II LLC
BRIEF

published on 05/22/2025 at 18:05, 8 months 13 days ago

Résultats de l'Assemblée Générale d'Oxurion

Actionnaires Assemblée Générale Titres Déclarations Prospectives Oxurion
BRIEF

published on 05/22/2025 at 18:05, 8 months 13 days ago

Results of the Oxurion General Meeting

Securities Shareholders Forward-looking Statements General Assembly Oxurion
PRESS RELEASE

published on 05/22/2025 at 18:00, 8 months 13 days ago

Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 13 mei 2025
Oxurion NV hield succesvol zijn jaarlijkse aandeelhoudersvergadering op 13 mei 2025. Alle agenda-items werden goedgekeurd. Meer informatie beschikbaar op www.oxurion.com

Euronext Brussel Oxurion NV Aandeelhoudersvergadering Biofarmaceutisch België
PRESS RELEASE

published on 05/22/2025 at 18:00, 8 months 13 days ago

Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025
Oxurion NV held its annual shareholders' meeting on May 13, 2025, in Leuven, Belgium. Shareholders approved all agenda items. Find more on Oxurion's website

Biopharmaceutical Clinical Data Euronext Brussels Annual Shareholders' Meeting Oxurion NV
BRIEF

published on 05/20/2025 at 18:05, 8 months 15 days ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF

published on 05/20/2025 at 18:05, 8 months 15 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/20/2025 at 18:00, 8 months 15 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding shareholding percentages falling below thresholds. Atlas Special Opportunities II LLC sold voting securities affecting percentages. Visit www.oxurion.com for more info

Belgium Oxurion NV Transparency Notifications Shareholding Percentages Biofarmaceutical Company
PRESS RELEASE

published on 05/20/2025 at 18:00, 8 months 15 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding changes in share ownership per Belgian Transparency legislation. Oxurion is a biopharmaceutical company developing ophthalmic therapies

Biopharmaceutical Share Ownership Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF

published on 05/16/2025 at 08:35, 8 months 19 days ago

Oxurion to Acquire Majority Stake in Axiodis CRO

Acquisition Revenue Growth Oxurion Axiodis CRO Clinical Biometrics

Accesswire

Published on 02/05/2026 at 01:35, 5 hours 55 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 7 hours 30 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 9 hours 5 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 13 hours 30 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 15 hours 15 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 07:00, 30 minutes ago

Aurubis AG: Aurubis achieves quarterly result in line with market expectations and upgrades 2025/26 forecast
Published on 02/05/2026 at 07:00, 30 minutes ago

FY2025: Resilient rental income and record new money in Asset Management ensure stable FFO I of CHF 4.22 per share; higher dividend of CHF 3.50 per share proposed
Published on 02/05/2026 at 07:00, 30 minutes ago

Rational AG reports growth of 8 percent after exchange rate adjustments – preliminary figures for the 2025 fiscal year
Published on 02/05/2026 at 07:00, 30 minutes ago

CGTN: Vision 2030: China's tech blueprint reshaping global innovation
Published on 02/05/2026 at 07:00, 30 minutes ago

SIG Group: New CEO Mikko Keto to start on 1 March 2026

Les Echos

Published on 02/04/2026 at 18:04, 13 hours 26 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 13 hours 26 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 13 hours 45 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 13 hours 45 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 13 hours 45 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE